首页> 外国专利> Derivative of 2 - (phenyl) - 2H - pyrazole carboxylic acid - 3 - 4 - N - (tioxo - heterociclil) phenyl imino Amide - and heterociclil derivatives and related compounds, procedures, Medications, Kit

Derivative of 2 - (phenyl) - 2H - pyrazole carboxylic acid - 3 - 4 - N - (tioxo - heterociclil) phenyl imino Amide - and heterociclil derivatives and related compounds, procedures, Medications, Kit

机译:2-(苯基)-2H-吡唑羧酸的衍生物-3-4-N-(噻吩基-杂基)苯基亚氨基酰胺-以及杂基衍生物和相关化合物,方法,药物,试剂盒

摘要

These compounds are inhibitors of XA coagulation factor and can be used in the prevention and / or treatment of thrombotic diseases and the treatment of tumors. Claim 1: compound of formula (1): D does not exist, or a saturated tar chain composed of 3 to 4 members, all or part of which is unsaturated, wherein 1 to 3 C atoms can be replaced by N and / or 1 to 2 C atoms, 1 to 2 O and / or 1 to 2 S atoms, But you can replace up to three C atoms and a monkey theredi or trisubstitution of the alkylene chain and / or of a nitrogen found there by Hal, A, - [C (R3) 2] n-Ar, - [C (R3) 2] n-Het, - [C (R3) 2] n-cycloalkyl, OR2, N (R2) 2, NO2, CN, COOR2, CON (R2) 2, NR2COA, NR2SO2A, COR2, SO2NR2, and / or S (O) mA, and where also a CH2 group of the alkylene chain may be replaced by a group C = O; M is a phenyl ring or an aromatic heterocycle that may contain 1-2 atoms of N, O and / or S; R1, R1 'are in each case, independently of each other,H. One or one or one or one or one or one or one or one or one or one or one or one or one or one or more are replaced by a conventional and formulaic amino protection group (2);R2 is H, A, - [C (R3) 2] n-Ar, - [C (R3) 2] n-Het, - [C (R3) 2] n-cycloalkyl, - [C (R3) 2] nN (R3) 2 or - [C (R3) 2] n-OR3; R2 'is H, A, - [C (R3) 2] n-Ar',- C (R3) 2 n-Het- [C (R3) 2] n-cycloalkyl, - [C (R3) 2] n-N (R3) 2 or - [C (R3) 2] n-OR3; R2 '' is H, A, - [C (R3) 2] n-Ar 'or - [C (R3) 2] n-cycloalkyl, - [C (R3) 2] nN (R3) 2 or - [C (R3) 2] n-OR3; R3 is H or A; W is a saturated, unsaturated or aromatic mono or bicyclic carbocycle or heterocycle with 1 to 4 atoms of N, O and / or S, which may be mono or disubstituted by R2; X is CONR2, CONR2C (R3) 2, -C (R3) 2NR2 or -C (R3) 2NR2C (R3) 2, -C (R3) 2O-,-C (R3) 2OC (R3) 2- or NR2CO; Y is alkylene, cycloalkylene, Het-diyl or Ar-diyl; T is a saturated, unsaturated or aromatic mono or bicyclic carbocycle or heterocycle with 1 to 4 atoms of N, O and / or S, which is mono or disubstituted by = S, = NR2, = N-CN, = N-NO2 , = NOR2, = NCOR2, = NCOOR2, = NOCOR2 and which may also be mono, disubstituted or trisubstituted by Hal, A, - [C (R3) 2] n-Ar, - [C (R3) 2] n-Het - [C (R3) 2] n-cycloalkyl, -OR3, N (R3) 2, NO2, CN, COOR2, CON (R2) 2, NR2COA, NR2CON (R2) 2, NR2SO2A, COR2, SO2NR2 and / or S (O) mA; A is C1-10 unbranched or branched alkyl,donde uno o dos grupos CH2 pueden estar reemplazados por tomos de O o S y 2Fo por grupos -CH 3DCH y 2Fo tambi n 1-7 tomos de H pueden estar reemplazados por F Ar es fenilo naftilo o bifenilo insustituido o mono di o trisustituido por u -O- C (R3) 2 o-COOR2Ar es fenilo o bencilo insustituido o mono o disustituido por Hal Het es un heterociclo mono o bic clico saturado no saturado o arom tico con 1 a 4 tomos de NO y 2Fo S que puede estar insustituido o mono di o trisustituido por el ox geno del - C (R3) 2 n-N (R2) 2 NO2 CN - C (R3) 2 n-COOR2- [C (R3) 2] n-CON (R2 ') 2, - [C (R3) 2] n-NR2'COA, NR2'CON (R2') 2, - [C (R3) 2] n- NR2'SO2A, COR2 ',So2nr2'y / O S (o) MA; hett1 is a single or double cycle heterocycle with one or two N, Y / or S atoms, which can be replaced, unsaturated, unsaturated or modified by carbide oxygen, = s (R3), 2, Hal, a, or2 ',N (R2) 2 NO2 CN COOR2CON (R2) 2 NR2 COA NR2 CON (R2) 2 NR2 SO2A COR2So2nr2 '' and / or s (o) MA; Hal is f, Cl, Br or I; n is 0, 1 or 2; m is 0, 1 or 2; or 1, 2 or 3; and stereoisomeric derivatives with the same drug use, including mixtures in various proportions.
机译:这些化合物是XA凝血因子的抑制剂,可用于预防和/或治疗血栓性疾病和治疗肿瘤。权利要求1:式(1)化合物:不存在D,或由3至4个成员组成的饱和焦油链,其全部或部分为不饱和的,其中1至3个碳原子可被N和/或1取代到2个C原子,1到2个O和/或1-2个S原子,但是您可以替换最多三个C原子和一个猴二或三取代亚烷基链和/或被Hal,A找到的氮, -[C(R3)2] n-Ar,-[C(R3)2] n-Het,-[C(R3)2] n-环烷基,OR2,N(R2)2,NO2,CN,COOR2, CON(R2)2,NR2COA,NR2SO2A,COR2,SO2NR2和/或S(O)mA,并且亚烷基链的CH2基团也可以被基团C = O取代; M是苯环或芳族杂环,可含有1-2个N,O和/或S原子; R 1,R 1'在每种情况下彼此独立,H。一个或一个或一个或一个或一个或一个或一个或一个或一个或一个或一个或一个或一个或一个或多个,被常规的和通式的氨基保护基团(2)取代; R 2为H,A,- [C(R3)2] n-Ar,-[C(R3)2] n-Het,-[C(R3)2] n-环烷基,-[C(R3)2] nN(R3)2或- [C(R3)2] n-OR3; R 2'为H,A,-[C(R3)2] n-Ar',-C(R3)2 n-Het- [C(R3)2] n-环烷基,-[C(R3)2] nN (R3)2或-[C(R3)2] n-OR3; R 2'是H,A,-[C(R3)2] n-Ar'或-[C(R3)2] n-环烷基,-[C(R3)2] nN(R3)2或-[C (R3)2] n-OR3; R3为H或A; W是具有1-4个N,O和/或S原子的饱和,不饱和或芳族单环或双环碳环或杂环,其可以被R2单或二取代; X是CONR2,CONR2C(R3)2,-C(R3)2NR2或-C(R3)2NR2C(R3)2,-C(R3)2O-,-C(R3)2OC(R3)2-或NR2CO; Y是亚烷基,亚环烷基,Het-二基或Ar-二基; T是具有1-4个N,O和/或S原子的饱和,不饱和或芳族单环或双环碳环或杂环,其被= S,= NR 2,= N-CN,= N-NO 2,单或二取代。 = NOR2,= NCOR2,= NCOOR2,= NOCOR2,并且也可以被Hal,A,-[[C(R3)2] n-Ar,-[C(R3)2] n-Het-单取代,二取代或三取代[C(R3)2]正环烷基,-OR3,N(R3)2,NO2,CN,COOR2,CON(R2)2,NR2COA,NR2CON(R2)2,NR2SO2A,COR2,SO2NR2和/或S( O)mA; A是C1-10直链或支链的烷基,CH 2在2至4链上-CH 3DCH y 2F在1-7到H上的X链上的烷基。邻苯二甲酸二异辛酯或邻苯二甲酸二异辛酯(R3)2邻-COOR2Ar苯酚或本尼西丁异辛基二恶英4拓扑图否磷酯的单价产地产生的根基-C(R3)2 nN(R2)2 NO2 CN-C(R3)2 n-COOR2- [C(R3)2 ] n-CON(R2')2,-[C(R3)2] n-NR2'COA,NR2'CON(R2')2,-[C(R3)2] n-NR2'SO2A,COR2', So2nr2'y / OS(o)MA; hett1是具有一个或两个N,Y /或S原子的单环或双环杂环,可被碳化氧(= R(R3),2,Hal,a或2',N取代,不饱和,不饱和或改性(R2)2 NO2 CN COOR2CON(R2)2 NR2 COA NR2 CON(R2)2 NR2 SO2A COR2So2nr2'和/或s(o)MA; Hal是f,Cl,Br或I; n为0、1或2; m为0、1或2;或1、2或3;或和具有相同药物用途的立体异构体衍生物,包括各种比例的混合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号